Ironwood Pharmaceuticals (IRWD) News Today $1.80 -0.11 (-5.53%) As of 03:21 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update CallFebruary 20 at 6:12 PM | investing.comIronwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update CallFebruary 20 at 5:21 PM | finance.yahoo.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Rating of "Moderate Buy" by BrokeragesIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the six analysts that are covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and three have issued a buy recoFebruary 20 at 4:11 AM | marketbeat.comIronwood Pharmaceuticals (IRWD) Expected to Announce Earnings on ThursdayFebruary 18 at 3:25 AM | americanbankingnews.comZacks Research Has Bullish Forecast for IRWD FY2025 EarningsFebruary 18 at 2:21 AM | americanbankingnews.comShort Interest in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Rises By 13.8%Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) was the recipient of a significant growth in short interest in January. As of January 31st, there was short interest totalling 10,750,000 shares, a growth of 13.8% from the January 15th total of 9,450,000 shares. Based on an average daily trading volume, of 2,880,000 shares, the short-interest ratio is presently 3.7 days. Approximately 6.9% of the shares of the company are short sold.February 17, 2025 | marketbeat.comWhat is Zacks Research's Estimate for IRWD FY2025 Earnings?Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Equities researchers at Zacks Research lifted their FY2025 EPS estimates for Ironwood Pharmaceuticals in a research report issued on Wednesday, February 12th. Zacks Research analyst R. Department now forecasts that the biotechnology comFebruary 17, 2025 | marketbeat.comZacks Research Issues Pessimistic Forecast for IRWD EarningsFebruary 16, 2025 | americanbankingnews.comWhat is Zacks Research's Forecast for IRWD Q1 Earnings?Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Equities researchers at Zacks Research decreased their Q1 2025 earnings per share estimates for Ironwood Pharmaceuticals in a report released on Wednesday, February 12th. Zacks Research analyst R. Department now anticipates that the bioFebruary 15, 2025 | marketbeat.comARMISTICE CAPITAL, LLC Increases Stake in Ironwood Pharmaceuticals IncFebruary 15, 2025 | gurufocus.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Insider Ronald Silver Sells 12,048 SharesFebruary 13, 2025 | insidertrades.comIronwood Pharmaceuticals chief legal officer sells shares worth $68,530February 13, 2025 | msn.comIronwood Pharmaceuticals' principal accounting officer sells $21,204 in stockFebruary 13, 2025 | msn.comIronwood Pharmaceuticals (IRWD) to Release Earnings on ThursdayIronwood Pharmaceuticals (NASDAQ:IRWD) will be releasing earnings before the market opens on Thursday, February 20, Financial Modeling Prep reports.February 13, 2025 | marketbeat.comRonald Silver Sells 12,048 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) StockIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) insider Ronald Silver sold 12,048 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $1.76, for a total value of $21,204.48. Following the completion of the transaction, the insider now directly owns 279,655 shares in the company, valued at approximately $492,192.80. This represents a 4.13 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.February 12, 2025 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) CMO Michael Shetzline Sells 41,269 SharesIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) CMO Michael Shetzline sold 41,269 shares of Ironwood Pharmaceuticals stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1.76, for a total transaction of $72,633.44. Following the completion of the transaction, the chief marketing officer now owns 554,007 shares of the company's stock, valued at $975,052.32. The trade was a 6.93 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.February 12, 2025 | marketbeat.comInsider Selling: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) CEO Sells 139,064 Shares of StockIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) CEO Thomas A. Mccourt sold 139,064 shares of Ironwood Pharmaceuticals stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $1.76, for a total transaction of $244,752.64. Following the sale, the chief executive officer now owns 1,160,634 shares in the company, valued at $2,042,715.84. This represents a 10.70 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.February 12, 2025 | marketbeat.comMillrose Properties Set to Join S&P SmallCap 600February 5, 2025 | prnewswire.comSTATE STREET CORP Reduces Stake in Ironwood Pharmaceuticals IncFebruary 5, 2025 | gurufocus.comLeerink Partnrs Brokers Lower Earnings Estimates for IRWDIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Leerink Partnrs reduced their Q1 2025 earnings per share (EPS) estimates for Ironwood Pharmaceuticals in a report released on Wednesday, January 29th. Leerink Partnrs analyst F. Khurshid now anticipates that the biotechnology company wiFebruary 3, 2025 | marketbeat.comIronwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the FutureJanuary 31, 2025 | businesswire.comIronwood Pharma: Strategic Growth Amidst Challenges, Driven by Apra’s PotentialJanuary 31, 2025 | markets.businessinsider.comVanguard Group Inc Reduces Stake in Ironwood Pharmaceuticals IncJanuary 31, 2025 | gurufocus.comLeerink Partnrs Issues Negative Forecast for IRWD EarningsIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Equities research analysts at Leerink Partnrs cut their Q4 2024 earnings per share estimates for Ironwood Pharmaceuticals in a research note issued on Wednesday, January 29th. Leerink Partnrs analyst F. Khurshid now anticipates that theJanuary 31, 2025 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Sets New 52-Week Low After Analyst DowngradeIronwood Pharmaceuticals (NASDAQ:IRWD) Sets New 1-Year Low After Analyst DowngradeJanuary 31, 2025 | marketbeat.comIronwood Pharma’s Strategic Shift and Financial Strain Lead to Hold RatingJanuary 31, 2025 | markets.businessinsider.comIronwood Pharmaceuticals stock tumbles following workforce cuts and revenue guidanceJanuary 30, 2025 | msn.comJMP Securities Issues Pessimistic Forecast for Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock PriceJMP Securities lowered their price objective on Ironwood Pharmaceuticals from $23.00 to $14.00 and set a "market outperform" rating on the stock in a research report on Thursday.January 30, 2025 | marketbeat.comIronwood stock target cut to $14 by JMP SecuritiesJanuary 30, 2025 | msn.comIronwood initiates apraglutide NDA submissionJanuary 30, 2025 | markets.businessinsider.comIronwood focuses on apraglutide amid workforce cutsJanuary 30, 2025 | msn.comIronwood Pharmaceuticals: Strategic Focus on Apraglutide Drives Long-Term Growth Potential and Buy RatingJanuary 30, 2025 | markets.businessinsider.comIronwood Pharmaceuticals announces workforce reductionJanuary 30, 2025 | msn.comPacer Advisors Inc. Increases Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Pacer Advisors Inc. increased its stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 4.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,730,771 shares of the bioteJanuary 28, 2025 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Shares Up 6.4% - What's Next?Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 6.4% - Time to Buy?January 27, 2025 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) have been given a consensus rating of "Moderate Buy" by the six analysts that are covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and three have assigned a buyJanuary 26, 2025 | marketbeat.comCalculating The Fair Value Of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)January 23, 2025 | finance.yahoo.comIronwood Pharmaceuticals (NASDAQ:IRWD) Price Target Lowered to $8.00 at Craig HallumCraig Hallum cut their target price on Ironwood Pharmaceuticals from $10.00 to $8.00 and set a "buy" rating on the stock in a research report on Wednesday.January 22, 2025 | marketbeat.comOzempic, Xtandi among next 15 drugs selected for U.S. price talksJanuary 18, 2025 | markets.businessinsider.comIronwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 3.7% - Here's What HappenedIronwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 3.7% - Time to Sell?January 17, 2025 | marketbeat.comOzempic is in the next round of Medicare drug price negotiations. See the full list of 15 medicationsJanuary 17, 2025 | cnbc.comZacks Research Issues Optimistic Estimate for IRWD EarningsIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Analysts at Zacks Research increased their FY2026 earnings per share (EPS) estimates for Ironwood Pharmaceuticals in a research note issued on Wednesday, January 8th. Zacks Research analyst R. Department now forecasts that the biotechnoJanuary 13, 2025 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 8.7% - Should You Sell?Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 8.7% - Here's What HappenedJanuary 10, 2025 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 4.1% - What's Next?Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 4.1% - Here's What HappenedJanuary 2, 2025 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Consensus Recommendation of "Moderate Buy" by AnalystsIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and tJanuary 1, 2025 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Sees Significant Growth in Short InterestIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) saw a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 12,080,000 shares, an increase of 7.7% from the November 30th total of 11,220,000 shares. Based on an average daily trading volume, of 1,740,000 shares, the short-interest ratio is currently 6.9 days. Currently, 7.8% of the shares of the company are short sold.January 1, 2025 | marketbeat.comJane Street Group LLC Boosts Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Jane Street Group LLC raised its position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 102.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 323,638 shares of the biotechnologyDecember 29, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 5% - Here's WhyIronwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 5% - What's Next?December 26, 2024 | marketbeat.comState Street Corp Has $40.87 Million Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)State Street Corp raised its position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 7.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 9,919,865 shares of the bioDecember 21, 2024 | marketbeat.comIronwood Pharma (IRWD) Receives a Buy from Craig-HallumDecember 20, 2024 | markets.businessinsider.com Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address IRWD Media Mentions By Week IRWD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRWD News Sentiment▼0.310.60▲Average Medical News Sentiment IRWD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRWD Articles This Week▼155▲IRWD Articles Average Week Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Innoviva News OPKO Health News Emergent BioSolutions News Rigel Pharmaceuticals News Codexis News XOMA News Verastem News Vanda Pharmaceuticals News Sangamo Therapeutics News Lexicon Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRWD) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRWD Stock Alerts